Senior insider sale
Chief Medical Officer at SOPHIA GENETICS SA — senior position signals high conviction
$384.5K
75.47K shares
MENU PHILIPPE plans to sell 75.47K shares of SOPHIA GENETICS SA valued at approximately $384.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Units
N/A
Pre-IPO
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/3/2025 | Restricted Stock Units N/A | 15K | — |
2/2/2020 | Pre-IPO N/A | 10K | — |
| Total | 25K | ||
Completed
Units to sell
5K
Market value
$27.5K
Units to sell
5K
Market value
$24.8K
Units to sell
5K
Market value
$24.8K
Units to sell
608.00
Market value
$2.8K
Units to sell
5K
Market value
$23.3K
Units to sell
5K
Market value
$24.1K
Units to sell
608.00
Market value
$3.2K
Units to sell
1.60K
Market value
$7.9K
Units to sell
4.40K
Market value
$21.0K
Units to sell
3.73K
Market value
$17.4K
Units to sell
1.93K
Market value
$9.2K
Units to sell
2.80K
Market value
$13.5K
Units to sell
2.40K
Market value
$11.7K
Planned — Approximate Date
Units to sell
32.39K
Market value
$173.3K
Units
75.47K
Value
$384.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 5K | $27.5K | — | Completed |
6/12/2026 | 5K | $24.8K | — | Completed |
5/26/2026 | 5K | $24.8K | — | Completed |
5/19/2026 | 608.00 | $2.8K | — | Completed |
5/12/2026 | 5K | $23.3K | — | Completed |
4/27/2026 | 5K | $24.1K | — | Completed |
4/20/2026 | 608.00 | $3.2K | — | Completed |
4/14/2026 | 1.60K | $7.9K | — | Completed |
4/13/2026 | 4.40K | $21.0K | — | Completed |
4/10/2026 | 3.73K | $17.4K | — | Completed |
4/9/2026 | 1.93K | $9.2K | — | Completed |
4/8/2026 | 2.80K | $13.5K | — | Completed |
4/7/2026 | 2.40K | $11.7K | — | Completed |
| Planned — Approximate Date | ||||
7/6/2026 | 32.39K | $173.3K | NASDAQ | Planned |
| Total | 75.47K | $384.5K | ||